What is CVE-2023-42435?

CVE-2023-42435 is a medium-severity vulnerability in Dexma Dexgate, classified under Cross-Site Request Forgery (CSRF). CVSS score: 5.5/10. Published 2023-10-19.

How severe is CVE-2023-42435?

Medium severity. CVSS v3 base score is 5.5 out of 10.

CSRF in Dexma Dexgate

CVE-2023-42435

The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.

Vulnerability class: CSRF (Cross-Site Request Forgery)

Published 2023-10-19 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 5.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L.

EPSS exploit prediction

EPSS: 0.002 (10.4th percentile), scored 2026-10-01.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 10th percentile — 10.4% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: +0.000

Affected products

Dexma Dexgate — versions 20130114, version 20130114

Weakness classification (CWE)

CWE-352 — Cross-Site Request Forgery (CSRF)

References

www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 (US Government Resource, Third Party Advisory)

Frequently asked questions

What is CVE-2023-42435?: CVE-2023-42435 is a medium-severity vulnerability in Dexma Dexgate, classified under Cross-Site Request Forgery (CSRF). CVSS score: 5.5/10. Published 2023-10-19.
How severe is CVE-2023-42435?: Medium severity. CVSS v3 base score is 5.5 out of 10.